Buruli Ulcer, Susceptibility To
Buruli ulcer is an infectious disease prevalent in many tropical and subtropical regions caused by infection with Mycobacterium ulcerans. It is the third most frequent mycobacterial disease in humans worldwide, after tuberculosis (OMIM ) and leprosy (OMIM ). Lesions are most common on exposed parts of the body, especially the limbs. Buruli ulcer derives its name from a county in Uganda, East Africa, north of Kampala, where the disease was found in the late 1950s in hundreds of people living near marshes and riverine areas near the Nile River (Clancey et al., 1961; Barker, 1971). The disease was first described in the medical literature in 1948 in a report on patients in Australia (MacCallum et al., 1948). Patients have also been reported from tropical areas in Latin America and Asia (Stienstra et al., 2006; van der Werf et al., 2005).
Genes related to Buruli Ulcer, Susceptibility To
Clinical FeaturesPhenotypes and symptoms related to Buruli Ulcer, Susceptibility To
Incidence and onset information— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.
Buruli Ulcer, Susceptibility To Is also known as mycobacterium ulcerans, susceptibility to.
Researches and researchersCurrently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.
Buruli Ulcer, Susceptibility To Recommended genes panels
|Panel Name, Specifity and genes Tested/covered|
By Fulgent Genetics Fulgent Genetics (United States).
You can get up to -7 more panels with our dedicated toolLearn more
Sources and references
You can check the following sources for additional information.OMIM Rare Disease Symptoms Checker
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCLEROSTEOSIS 2; SOST2 SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA ESTROGEN RESISTANCE; ESTRR MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H LARON SYNDROME